<DOC>
	<DOC>NCT00190736</DOC>
	<brief_summary>A study to compare the effect of once-daily atomoxetine versus placebo in treating symptoms of ADHD in adults for up to 6 months.</brief_summary>
	<brief_title>Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)</brief_title>
	<detailed_description />
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Male and Female patients with ADHD ages 1854. Patient must have ADHD symptoms that cause problem(s) in the home setting. Have failed to respond to an adequate trial of treatment with an ADHD stimulant medication, bupropion, or other nonstimulant medication. Are taking any antipsychotic medication or mood stabilizers within 8 weeks of Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>